Skip to main content

Intellia Therapeutics, Inc.

NTLA
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
SEC CIK
0001652130

In the last 90 days, Intellia Therapeutics, Inc. insiders filed 0 open-market purchases and 4 sales; 329 institutions reported holding it in 13F filings for Q2 2026, worth $2.43B in total; ARK Invest is the only superinvestor holding it.

13F holders, Q1 2026

Institutional positions in Intellia Therapeutics, Inc. as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
306
+16 vs. Q4 2025
Shares held
110.4M
+19.2M (+21.1%) vs. Q4 2025
Total value
$1.41B
+$592.7M (+72.1%) vs. Q4 2025
New holders
63
128 more added
Sold out
47
63 more reduced

5 institutions that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q4 2025: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting NTLA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2026: 306 institutions
Q1 2021: 261 institutionsQ2 2021: 337 institutionsQ3 2021: 366 institutionsQ4 2021: 372 institutionsQ1 2022: 348 institutionsQ2 2022: 301 institutionsQ3 2022: 321 institutionsQ4 2022: 304 institutionsQ1 2023: 291 institutionsQ2 2023: 292 institutionsQ3 2023: 286 institutionsQ4 2023: 293 institutionsQ1 2024: 284 institutionsQ2 2024: 291 institutionsQ3 2024: 284 institutionsQ4 2024: 295 institutionsQ1 2025: 296 institutionsQ2 2025: 283 institutionsQ3 2025: 284 institutionsQ4 2025: 295 institutionsQ1 2026: 306 institutionsQ2 2026: 329 institutions
Value heldQ1 2026: $1.41B
Q1 2021: $5.07BQ2 2021: $10.0BQ3 2021: $8.34BQ4 2021: $7.60BQ1 2022: $4.71BQ2 2022: $3.44BQ3 2022: $3.81BQ4 2022: $2.72BQ1 2023: $2.93BQ2 2023: $3.19BQ3 2023: $2.53BQ4 2023: $2.60BQ1 2024: $2.51BQ2 2024: $2.02BQ3 2024: $1.92BQ4 2024: $1.16BQ1 2025: $720.3MQ2 2025: $933.8MQ3 2025: $1.80BQ4 2025: $938.9MQ1 2026: $1.41BQ2 2026: $2.43B
Institutions holding NTLA and their total value by quarter
QuarterHoldersValue
Q2 2026329$2.43B
Q1 2026306$1.41B
Q4 2025295$938.9M
Q3 2025284$1.80B
Q2 2025283$933.8M
Q1 2025296$720.3M
Q4 2024295$1.16B
Q3 2024284$1.92B
Q2 2024291$2.02B
Q1 2024284$2.51B
Q4 2023293$2.60B
Q3 2023286$2.53B
Q2 2023292$3.19B
Q1 2023291$2.93B
Q4 2022304$2.72B
Q3 2022321$3.81B
Q2 2022301$3.44B
Q1 2022348$4.71B
Q4 2021372$7.60B
Q3 2021366$8.34B
Q2 2021337$10.0B
Q1 2021261$5.07B

Institutions, Q1 2026

Shares, value and share of portfolio for each institution holding Intellia Therapeutics, Inc.; share changes are against Q4 2025.

Institutions holding NTLA in Q1 2026
InstitutionSharesValue% of portfolioChange in sharesAction
Vanguard Capital Management LLC5,084,105$65.2M0.00%+5,084,105New
D. E. Shaw & Co., Inc.5,728,177$73.4M0.06%+397,113+7.4%Added
Vanguard Portfolio Management LLC6,223,325$79.8M0.00%+6,223,325New
State Street Corp6,922,676$88.7M0.00%+503,840+7.8%Added
BlackRock, Inc.12,155,806$155.8M0.00%+1,878,957+18.3%Added
ARK Investment Management LLCSuperinvestorARK Invest14,509,247$186.0M1.45%+301,923+2.1%Added
Two Sigma Advisers, LP0$00.00%−2,346,317−100.0%Sold out
Renaissance Technologies LLC0$00.00%−1,672,700−100.0%Sold out
First Trust Advisors LP0$00.00%−276,855−100.0%Sold out
Headlands Technologies LLC0$00.00%−243,903−100.0%Sold out
Bridgewater Associates, LP0$00.00%−223,166−100.0%Sold out
Qube Research & Technologies Ltd0$00.00%−158,235−100.0%Sold out
Edgestream Partners, L.P.0$00.00%−111,159−100.0%Sold out
Panagora Asset Management Inc0$00.00%−99,301−100.0%Sold out
Discovery Value Fund0$00.00%−97,976−100.0%Sold out
Freestone Grove Partners LP0$00.00%−88,406−100.0%Sold out
Schonfeld Strategic Advisors LLC0$00.00%−75,244−100.0%Sold out
Susquehanna Fundamental Investments, LLC0$00.00%−69,226−100.0%Sold out
Campbell & CO Investment Adviser LLC0$00.00%−55,319−100.0%Sold out
Dark Forest Capital Management LP0$00.00%−44,947−100.0%Sold out
Entropy Technologies, LP0$00.00%−37,142−100.0%Sold out
Arete Wealth Advisors, LLC0$00.00%−30,843−100.0%Sold out
Graham Capital Management, L.P.0$00.00%−29,346−100.0%Sold out
VARCOV Co.0$00.00%−29,109−100.0%Sold out
Quest Partners LLC0$00.00%−27,588−100.0%Sold out
Virtu Financial LLC0$00.00%−27,260−100.0%Sold out
Steel Peak Wealth Management LLC0$00.00%−21,006−100.0%Sold out
Caption Management, LLC0$00.00%−20,000−100.0%Sold out
SummitTX Capital, L.P.0$00.00%−17,287−100.0%Sold out
Farringdon Capital, Ltd.0$00.00%−15,291−100.0%Sold out
Twinbeech Capital LP0$00.00%−15,289−100.0%Sold out
Quantbot Technologies LP0$00.00%−14,805−100.0%Sold out
NEOS Investment Management LLC0$00.00%−14,260−100.0%Sold out
Nano Cap New Millennium Growth Fund L P0$00.00%−12,500−100.0%Sold out
Walleye Trading LLC0$00.00%−11,663−100.0%Sold out
Nomura Holdings Inc0$00.00%−10,995−100.0%Sold out
Amundi0$00.00%−10,161−100.0%Sold out
CAPROCK Group, Inc.0$00.00%−10,159−100.0%Sold out
Daiwa Securities Group Inc.0$00.00%−7,536−100.0%Sold out
Walleye Capital LLC0$00.00%−6,580−100.0%Sold out
Amalgamated Bank0$00.00%−3,233−100.0%Sold out
Bellevue Group AG0$00.00%−2,978−100.0%Sold out
Quattro Advisors LLC0$00.00%−674−100.0%Sold out
CWM Advisors, LLC0$00.00%−487−100.0%Sold out
PEAK6 LLC0$00.00%−374−100.0%Sold out
Umb Bank N A0$00.00%−250−100.0%Sold out
Armstrong Advisory Group, Inc0$00.00%−144−100.0%Sold out
Torren Management, LLC0$00.00%−99−100.0%Sold out
Glen Eagle Advisors, LLC0$00.00%−50−100.0%Sold out
Elyxium Wealth, LLC0$00.00%−38−100.0%Sold out
Adirondack Trust Co0$00.00%−24−100.0%Sold out
SHP Wealth Management0$00.00%−16−100.0%Sold out
Innovative Advisory Group, LLC0$00.00%−5−100.0%Sold out
Vanguard Group Inc––––Not filed
CIBC Private Wealth Group, LLC––––Not filed
Comerica Bank––––Not filed
Global Retirement Partners, LLC––––Not filed
GPS Wealth Strategies Group, LLC––––Not filed